Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis
Clinical trial NCT03813160 · COMPLETED
Trial details
- NCT number
- NCT03813160
- Sponsor
- Corbus Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-17
- Primary completion
- 2021-03-31
- Enrollment
- 176
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.